Sepsis - the challenges of science, politics and society

Leopoldina Symposium 2016
German National Academy of Sciences Leopoldina founded in 1652, the Leopoldina brings together some 1,500 outstanding scientists from about 30 countries. It is dedicated to the advancement of science for the benefit of humankind and to shaping a better future. In its role as the German National Academy of Sciences, the Leopoldina represents the German scientific community in international committees. It offers unbiased scientific opinions on political and societal questions, publishing independent studies of national and international significance. The Leopoldina promotes scientific and public debate, supports young scientists, confers awards for scientific achievements, conducts research projects, and campaigns for the human rights of persecuted scientists.

Exhibit

Symposia

Workshops

Organiser

Sponsor



Sepsis continues to cause millions of deaths worldwide of which at least two million fatalities could be avoided each year by preventive measures such as vaccination of at risk populations, better sanitation and clean care, as well as by early recognition and most basic elements of care. In addition, at least 2 million sepsis survivors per year suffer from significant long term complications of the syndrome. Currently, adequate treatment facilities for most of these patients are missing. Despite its high and increasing incidence sepsis is poorly recognized by health authorities, health care workers, policymakers, lay people and media. The implementation of effective measures for sepsis control and the development of improved infection and sepsis diagnostics, effective antimicrobials and sepsis specific therapies are urgently needed.

This Leopoldina Symposium brings together highly ranked policy makers, representatives of national and international health care authorities, most renowned clinical scientists, basic researchers, representatives of highly innovative diagnostic and pharmaceutic companies, media and communication experts and sepsis survivors to learn from each other about the most effective ways to:

  • Increase vaccination rates and adherence to hygienic standards
  • Improve preparedness in case of further pandemics
  • Increase awareness for sepsis among lay people and health care providers
  • Foster quality improvement projects in the hospital and outpatient setting
  • Implement antibiotic stewardship programs and stop the misuse of antimicrobials
  • Overcome the gap between resistance, novel and effective antimicrobials
  • Encourage the development of cost-effective diagnostics and sepsis-specific therapeutics
  • Develop and provide adequate treatment concepts for sepsis sequelae

Participation at the symposium is free of charge, but registration is required.

Please fill the form for ONLINE REGISTRATION

Program Thursday, 10 March 2016

Opening session

Chairs:

E. Rietschel, Berlin / P. Suter, Geneva

Start: 10:30

Welcome and introduction

W. Tiefensee, TMWWDG

G. Berg, Leopoldina

W. Rosenthal, FSU

K. Benndorf, UKJ

10:50 Keynote Lecture:

Role of poverty and environment for public health

A. Steiner, Executive Director of United Nations Environment Programme (UNEP) and Under-Secretary-General of the United Nations

11:20

The German strategy for infection and sepsis control

L. H. Wieler, RKI

11:40

The WHO approach to sepsis control

N. Shindo, WHO

12:00

Lessons to be learned from the Ebola epidemic

T. Stöbe, MSF

12:20

The burden of sepsis in children

N. Kissoon, Canada

12:40

The burden of sepsis - a call to action

K. Reinhart, Jena

13:00 Lunch Break

The challenges of science

Chairs:

M. Quintel, Göttingen / T. Hein, Dallas

14:00

Challenges in the development of novel diagnostics and therapeutics in sepsis

N. Riedemann, Jena

14:20

Challenges to preserve and develop effective antimicrobials

M. Pletz, Jena

14:40

Role and challenges of clinical sepsis research

S. Finfer, Australia

15:00

Lessons learned from cancer

M. Löffler, Leipzig

15:20

Lessons learned from cardiology

C. Schulze, Jena

15:40 Coffee Break

Novel approaches to sepsis control and health promotion

Chairs:

C. Spies, Berlin / R. Rossaint, Aachen

16:00

The Surviving Sepsis Campaign approach to guideline implementation

H. Gerlach, Berlin

16:20

The National Irish initiative to sepsis control

V. Hamilton, Ireland

16:40

The Scottish National Health Service approach to quality improvement

K. Rooney, Scotland

Novel approaches to sepsis control and health promotion II

Chairs:

K. Werdan, Halle / M. Weigand, Heidelberg

17:00

The NRC for Surveillance and Nosocomial infection’s approach

P. Gastmeier, Berlin

17:20

The Initiative for Quality in Medicine’s approach

A. Meier-Hellmann, Erfurt

17:40

The Center for Sepsis Control and Care’s approach

H. Rüddel, Jena

18:00

The perspective of a sepsis victim

A. Trumann, Heeslingen

Öffentlicher Abendvortrag

Moderation:

M. Bucher, Halle

19:00

Sepsis vermeiden und früh erkennen

F. M. Brunkhorst, Jena

Program Friday, 11 March 2016

Novel approaches to sepsis control and health promotion

Chairs:

B. Böttiger, Cologne / B. Löffler, Jena

08:30

The US approach to quality improvement for sepsis management

M. Levy, USA

08:50

The UK Sepsis Trust approach to awareness & quality improvement

R. Daniels, UK

09:10

Prepardness and the role of ICUs in the fight against pandemics

J. Marshall, Canada

09:30

The Turkish approach to improve sepsis awareness and sepsis management.

N. Unal, Turkey

09:50

The role of media during health crises

J. Müller-Jung, FAZ

10:10

New approaches to vaccination and health promotion

C. Betsch, Erfurt

10:30 Coffee break

Roadmap for development of innovative vaccines, diagnostics and therapeutics I

Chairs:

T. Koch, Dresden / L. Gattinoni, Milan

Role of private public partnership for development of innovative vaccines, diagnostics and therapeutics Lessons learned and expectations of:

Chairs:

M. Hecker, Greifswald / H. van Aken, Münster

15:30

A researcher and later entrepreneur

E. Ermantraut, Blink GmbH Jena

15:50

An international diagnostics corporate

V. Liebenberg, Thermo Fisher Scientific Hennigsdorf/Berlin

16:10

A global medical products manufacturer

M. Lugan, B. Braun Melsungen AG

16:30

A biotech company

J. Struck, AdrenoMed AG Hennigsdorf/Berlin

16:50

A university spin-off

N. Riedemann, inflaRx Jena

17:10 Closing remarks

M. Bauer, Jena




More events

C@MU 2024 Congress

Wed, 3 Apr 2024 - Thu, 4 Apr 2024


Hôpital Xavier Arnozan
Avenue du Haut-Lévêque PESSAC, Avenue du Haut-Lévêque 33604
CEDEX
SYNCOPE 2024- International Interdisciplinary Symposium

Sat, 6 Apr 2024 - Sat, 6 Apr 2024


Ella-Trebe-Straße 5,
Berlin, 10557
Germany
ISHLT 2024

Wed, 10 Apr 2024 - Sat, 13 Apr 2024


5. května 1640
Prague 4, 140 00
Czech Republic
NATA24 Annual Symposium

Thu, 18 Apr 2024 - Sat, 20 Apr 2024


P.zza Costituzione, 4/a
Bologna, 40128
Italy
12th EuroELSO Congress 2024

Wed, 24 Apr 2024 - Sat, 27 Apr 2024


Marii Konopnickiej 17
Kraków, 30-302
Poland
20th Annual Critical Care Symposium

Thu, 25 Apr 2024 - Fri, 26 Apr 2024


Portland Street
Manchester, M1 4PH
UK
13th Ultrasound In Acute Care 2024

Thu, 25 Apr 2024 - Fri, 26 Apr 2024


Portland Street
Manchester, M1 4PH
UK

Related articles